The clinical significance of persistently normal ALT in chronic hepatitis B infection

被引:338
作者
Lai, Michelle [1 ]
Hyatt, Benjamin J. [1 ]
Nasser, Imad [1 ]
Curry, Michael [1 ]
Afdhal, Nezam H. [1 ]
机构
[1] Harvard Univ, Sch Med, Div Hepatol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
关键词
liver biopsy; fibrosis; normal ALT; hepatitis B;
D O I
10.1016/j.jhep.2007.07.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Chronic hepatitis B virus (HBV) disease is caused by both necroinflammation and active viral replication. The role of ALT levels as a predictor of liver injury has recently been questioned. The aim of the study was to determine whether normal ALT is associated with liver injury in a cohort of HBV patients undergoing liver biopsy. Methods: This is a retrospective review of chronic HBV patients divided into 3 groups; (1) persistently normal ALT (PNALT); (2) ALT 1-1.5X ULN and (3) ALT > 1.5X ULN. Multiple clinical, biochemical, virological variables were evaluated. Results: One hundred and ninety-two patients met the inclusion criteria, 59 with PNALT, 26 with ALT 1-1.5X ULN, and 107 with ALT > 1.5X ULN. Increasing age, higher ALT, higher grade of inflammation on biopsy, and HBeAg positivity predicted fibrosis. 18% of patients with PNALT had stage 2+ fibrosis and 34% had grade 2 or 3 inflammation. Overall 37% of patients with PNALT had significant fibrosis or inflammation. Subgroup analysis showed the majority with fibrosis belonged to the high normal ALT group and that only a minority who were young and immune tolerant had significant findings on biopsy. Conclusions: There is significant fibrosis and inflammation in 37% of patients with PNALT and a liver biopsy should be considered in patients older than 40 with high normal ALT. (c) 2007 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:760 / 767
页数:8
相关论文
共 16 条
[1]   Chronic hepatitis B virus carriers in the immunotolerant phase of infection:: Histologic findings and outcome [J].
Andreani, Tony ;
Serfaty, Lawrence ;
Mohand, Djamila ;
Dernaika, Salem ;
Wendum, Dominique ;
Chazouilleres, Olivier ;
Poupon, Raoul .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (05) :636-641
[2]  
CECIL RL, 2000, CECIL TXB MED, P2318
[3]  
FATTOVICH G, 1995, HEPATOLOGY, V21, P77
[4]   Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population [J].
Harris, RA ;
Chen, G ;
Lin, WY ;
Shen, FM ;
London, WT ;
Evans, AA .
CANCER CAUSES & CONTROL, 2003, 14 (10) :995-1000
[5]   Predicting cirrhosis risk based on the level of circulating hepatitis B viral load [J].
Iloeje, UH ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Chen, CJ .
GASTROENTEROLOGY, 2006, 130 (03) :678-686
[6]   A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: An update [J].
Keeffe, Emmet B. ;
Dieterich, Douglas T. ;
Han, Steven-Huy B. ;
Jacobson, Ira M. ;
Martin, Paul ;
Schiff, Eugene R. ;
Tobias, Hillel ;
Wright, Teresa L. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (08) :936-962
[7]  
LIAW YF, 1989, LIVER, V9, P235
[8]   THE DEVELOPMENT OF CIRRHOSIS IN PATIENTS WITH CHRONIC TYPE-B HEPATITIS - A PROSPECTIVE-STUDY [J].
LIAW, YF ;
TAI, DI ;
CHU, CM ;
CHEN, TJ .
HEPATOLOGY, 1988, 8 (03) :493-496
[9]   Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels [J].
Lin, Chih-Lin ;
Liao, Li-Ying ;
Liu, Chun-Jen ;
Yu, Ming-Whei ;
Chen, Pei-Jer ;
Lai, Ming-Yang ;
Chen, Ding-Shinn ;
Kao, Jia-Horng .
HEPATOLOGY, 2007, 45 (05) :1193-1198
[10]   Chronic hepatitis B [J].
Lok, Anna S. F. ;
McMahon, Brian J. .
HEPATOLOGY, 2007, 45 (02) :507-539